UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051443
Receipt number R000056488
Scientific Title Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.
Date of disclosure of the study information 2023/07/01
Last modified on 2024/01/13 14:00:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease - Evaluation Study for MRI Utilization -.

Acronym

Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.

Scientific Title

Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.

Scientific Title:Acronym

Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.

Region

Japan


Condition

Condition

Chronic Kidney Disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Development of clinical indicators that can be used to evaluate the pathophysiology of patients with chronic kidney disease.

Basic objectives2

Others

Basic objectives -Others

1) Evaluation of renal morphology and physiological parameters by magnetic resonance imaging
2) Evaluation of target molecule concentrations in blood and urine

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Results of blood and urine biomarkers and magnetic resonance imaging.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with chronic kidney disease who are attending the Department of Nephrology at Saitama Medical University Hospital approximately every 1-2 months and who have indicated their willingness to consent to the study after receiving a written explanation.

Key exclusion criteria

(1) Patients deemed inappropriate by the principal investigator
(e.g., after introduction of renal replacement therapy, children (under 18 years old), acute kidney injury, unilateral renal disease (e.g., renal vascular hypertension), renal tumor, severe edematous disease (e.g., nephrotic syndrome), cystic disease, postrenal kidney disease)
(2) Patients who have changed the content of the given medication in the initial entry
(At the time of the change in the content of the medication because the purpose is to confirm the baseline [MRI, biomarkers] of the case.)
(3) Those whose MRI images or laboratory test results are deemed inappropriate for evaluation
(When the renal parenchyma is poorly delineated on MRI due to artifacts from body movement, atrophy, cysts, scarring, etc., or when the specimen acquisition and processing process is inappropriate and is inferred not to reflect the pathophysiology of the subject)

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Hirokazu
Middle name
Last name Okada

Organization

Saitama Medical University

Division name

Nephrology

Zip code

350-0495

Address

38 Morohongo Moroyama-machi Iruma-gun Saitama Japan

TEL

049-276-1611

Email

hirookda@saitama-med.ac.jp


Public contact

Name of contact person

1st name Hirokazu
Middle name
Last name Okada

Organization

Saitama Medical University

Division name

Nephrology

Zip code

350-0495

Address

38 Morohongo Moroyama-machi Iruma-gun Saitama Japan

TEL

049-276-1611

Homepage URL


Email

hirookda@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

CHUGAI PHARMACEUTICAL CO.,LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University

Address

38 Morohongo Moroyama-machi Iruma-gun Saitama Japan

Tel

049-276-1354

Email

hirb@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 13 Day

Date of IRB

2023 Year 07 Month 15 Day

Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2025 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study aims to develop clinical indices for chronic kidney disease (CKD) through analysis of renal MRI and blood and urine biomarkers that can be used to understand the pathophysiology of CKD patients and to evaluate new drugs. This is an exploratory (noninterventional) observational clinical study.


Management information

Registered date

2023 Year 06 Month 24 Day

Last modified on

2024 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056488


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name